| P2093 | author name string | David J Munroe | |
| | Brian Luke | |
| | Hassan Ashktorab | |
| | Shahina Akter | |
| | Iqbal Unnisa Ali | |
| | John Kwagyan | |
| | Duane Smoot | |
| | Zhonghe Sun | |
| | Shirley Tsang | |
| | Ahmad Akhgar | |
| | Richard Poirier | |
| | Lucile Adam-Campbell | |
| P2860 | cites work | Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma | Q25255846 |
| | The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland | Q28184500 |
| | Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia | Q28194221 |
| | COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States) | Q28195167 |
| | Epidemiology of non-steroidal anti-inflammatory drugs and cancer | Q28196393 |
| | Celecoxib for the prevention of sporadic colorectal adenomas | Q28200368 |
| | Celecoxib for the prevention of colorectal adenomatous polyps | Q28200375 |
| | PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs | Q28210376 |
| | Cancer statistics, 2007 | Q29547293 |
| | The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 |
| | Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 |
| | A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants | Q34568722 |
| | Introns in gene evolution | Q35179945 |
| | Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study | Q36695052 |
| | Racial disparities in colorectal cancer | Q36837807 |
| | COX-2 gene promoter haplotypes and prostate cancer risk | Q38345290 |
| | Genetic variation in the COX-2 gene and the association with prostate cancer risk | Q44545695 |
| | Inflammation-related gene polymorphisms and colorectal adenoma | Q45004211 |
| | Methods and strategies to recruit African Americans into cancer prevention surveillance studies | Q46988251 |
| | Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. | Q54613762 |
| | Human genome-wide screen of haplotype-like blocks of reduced diversity | Q58454077 |
| | Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer | Q79411107 |
| P433 | issue | 5B | |
| P921 | main subject | colorectal adenoma | Q2825480 |
| P304 | page(s) | 3119-3123 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Anticancer Research | Q326290 |
| P1476 | title | Protective effect of Cox-2 allelic variants on risk of colorectal adenoma development in African Americans | |
| P478 | volume | 28 | |